Casdin Capital, LLC’s Beam Therapeutics Inc Position
Does Casdin Capital, LLC own Beam Therapeutics Inc (BEAM)? Yes — 1.35M shares worth $32M (+2.44% of its 13F portfolio) as of Q1 2026, down from 1.60M shares the prior filed quarter.
Position Value
$32M
Q1 2026
Shares
1.35M
% of Portfolio
+2.44%
Quarters Held
22
currently held
Position History BEAM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.35M | $32M | +2.44% |
| Q4 2025 | 1.60M | $44M | +2.75% |
| Q3 2025 | 1.60M | $39M | +3.24% |
| Q2 2025 | 1.45M | $25M | +2.25% |
| Q1 2025 | 1.43M | $28M | +2.27% |
| Q4 2024 | 1.25M | $31M | +2.06% |
| Q3 2024 | 775.0K | $19M | +1.27% |
| Q2 2024 | 675.0K | $16M | +1.21% |
| Q1 2024 | 675.0K | $22M | +1.66% |
| Q4 2023 | 528.0K | $14M | +1.41% |
| Q3 2023 | 570.0K | $14M | +1.52% |
| Q2 2023 | 570.0K | $18M | +1.59% |
| Q1 2023 | 570.0K | $17M | +1.44% |
| Q4 2022 | 370.0K | $14M | +1.12% |
| Q3 2022 | 370.0K | $18M | +1.16% |
| Q2 2022 | 375.0K | $15M | +1.23% |
| Q1 2022 | 818.8K | $47M | +2.10% |
| Q4 2021 | 818.8K | $65M | +1.84% |
| Q3 2021 | 818.8K | $71M | +1.77% |
| Q2 2021 | 818.8K | $105M | +2.68% |
| Q1 2021 | 818.8K | $66M | +1.95% |
| Q4 2020 | 460.0K | $38M | +1.11% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Casdin Capital, LLC’s full portfolio or all institutional holders of BEAM.